throbber
I 1111111111111111 1111111111 111111111111111 11111 lllll 111111111111111 11111111
`
`US010478453Bl
`
`c12) United States Patent
`Maloney et al.
`
`(10) Patent No.: US 10,478,453 Bl
`(45) Date of Patent:
`Nov. 19, 2019
`
`(54) STABLE, HIGHLY PURE L-CYSTEINE
`COMPOSITIONS FOR INJECTION AND
`METHODS OF USE
`
`(71) Applicant: Exela Pharma Sciences, LLC, Lenoir,
`NC (US)
`
`(72)
`
`Inventors: John Maloney, Salisbury, NC (US);
`Aruna Koganti, Lenoir, NC (US);
`Phanesh Koneru, Waxhaw, NC (US)
`
`(73) Assignee: Exela Pharma Sciences, LLC, Lenoir,
`NC (US)
`
`( *) Notice:
`
`Subject to any disclaimer, the term ofthis
`patent is extended or adjusted under 35
`U.S.C. 154(b) by O days.
`
`(21) Appl. No.: 16/248,460
`
`(22) Filed:
`
`Jan. 15, 2019
`
`(51)
`
`(52)
`
`Int. Cl.
`A61K 9/00
`A61K 33/06
`A61K 31/191
`A61K 47102
`A61K 33/36
`A61K 331241
`A61K 33/28
`A61K 33/00
`A61K 311405
`
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(2019.01)
`(2006.01)
`(2006.01)
`(2006.01)
`(Continued)
`
`U.S. Cl.
`CPC .............. A61K 33/06 (2013.01); A23L 33/16
`(2016.08); A23L 33/175 (2016.08); A61K
`9/0029 (2013.01); A61K 31/095 (2013.01);
`A61K 31/191 (2013.01); A61K 31/198
`(2013.01); A61K 311401 (2013.01); A61K
`311405 (2013.01); A61K 3114172 (2013.01);
`A61K 33/00 (2013.01); A61K 331241
`(2019.01); A61K 33/28 (2013.01); A61K 33/36
`
`(2013.01); A61K 47102 (2013.01); A23V
`2002/00 (2013.01); A61J 1/1412 (2013.01)
`(58) Field of Classification Search
`CPC ..... A61K 9/0029; A61K 31/095; A61K 47/02
`See application file for complete search history.
`
`(56)
`
`References Cited
`
`U.S. PATENT DOCUMENTS
`
`6,992,218 B2
`7,323,206 Bl
`9,220,700 B2
`
`1/2006 Dietlin et al.
`1/2008 Driscoll et al.
`12/2015 Savarese et al.
`
`OTHER PUBLICATIONS
`
`Jalilehvand et al (Inorg. Chem., 2015, 54 (5), pp. 2160-2170). (Year:
`2015).*
`
`(Continued)
`
`Primary Examiner - Benjamin J Packard
`(74) Attorney, Agent, or Firm -Alston & Bird LLP
`
`ABSTRACT
`(57)
`The subject matter described herein is directed to stable
`L-cysteine compositions for injection, comprising: L-cyste(cid:173)
`ine or a pharmaceutically acceptable salt thereof and/or
`hydrate thereof in an amount from about 10 mg/mL to about
`100 mg/mL; Aluminum in an amount from about 1.0 parts
`per billion (ppb) to about 250 ppb; cystine in an amount
`from about 0.01 wt% to about 2 wt% relative to L-cysteine;
`pyruvic acid in an amount from about 0.01 wt % to about 2
`wt % relative to L-cysteine; a pharmaceutically acceptable
`carrier, comprising water; headspace 0 2 that is less than
`1.0%; dissolved oxygen present in the carrier in an amount
`from about 0.01 parts per million (ppm) to about 1 ppm,
`wherein the composition is enclosed in a single-use con(cid:173)
`tainer having a volume of from 10 mL to 100 mL. Also
`described are compositions for a total parenteral nutrition
`regimen and methods for their use.
`
`22 Claims, 5 Drawing Sheets
`
`-------------------------------------------------------------------------------------------------------------------------------------------------------------·
`
`Dissolved Oxygen Levels per Tray
`
`14.0
`
`12.0
`
`10.0
`
`C!!.O
`0
`
`4.0
`
`2.0
`
`0.0
`
`Final Dissolved Oxygen Post Filling -Pre HSR
`
`Post Filling - During
`
`~Trayl [
`~Tr,iy 2 :
`~-.-.»-.-.-.Tr;,y 3 [
`~Tray4 [
`~Tray 17:
`w.%._._._ Tray 18[
`~ .... ~ ... fray19:
`-Tray20[
`•.•.•.•.•.•.•.•. fray 21[
`~Tray 22:
`•.•.• ;;:;-•.•.• Tray 23 [
`
`·.:::::::;:::::. ~~:; ~~ ~
`
`········•:•.····Tray 38 [
`•·•·····:•,·,·,·Tray 39;
`•···•·.:.·•···•T;ay40[
`I
`Post HSR -Capping•
`
`·················C·o·~·p~~~~i~~ ................................................. L~a.d.in.g.~f.~y~················ Filled Vials ................ 1
`
`Eton Ex. 1101
`1 of 43
`
`

`

`US 10,478,453 Bl
`Page 2
`
`(51)
`
`Int. Cl.
`A61K 311401
`A61K 3114172
`A23L 331175
`A23L 33/16
`A61K 31/198
`A61K 31/095
`A61J 1/14
`
`(2006.01)
`(2006.01)
`(2016.01)
`(2016.01)
`(2006.01)
`(2006.01)
`(2006.01)
`
`(56)
`
`References Cited
`
`OTHER PUBLICATIONS
`
`Sigma-Aldrich product information, L-cysteine hydrochloride
`mononyhdrate (05/06). (Year: 2006).*
`Whiting et al (Journal of Food Protection, vol. 55, No. 1, pp. 23-27,
`Jan. 1992). (Year: 1992).*
`Lima-Rogel et al ((2016), Aluminum Contamination in Parenteral
`Nutrition Admixtures for Low-Birth-Weight Preterm Infants in
`Mexico. Journal of Parenteral andEnteral Nutrition, 40: 1014-1020)
`(Year: 2016).*
`Hintz, et al ((2008), Aluminum Exposure From Pediatric Parenteral
`Nutrition: Meeting the New FDA Regulation. JPEN J Parenter
`Enteral Nutr, 32: 242-246). (Year: 2008). *
`"Guidelines for the Use of Parenteral and Enteral Nutrition in Adult
`and Pediatric Patients," ASPEN Board of Directors and the Clinical
`Guidelines Task Force, Journal of Parenteral and Enteral Nutrition,
`26(1 Suppl.):1SA-138SA, (2002).
`"Acetadote (acetylcysteine) injection, for intravenous use: Prescrib(cid:173)
`ing Information [package insert]," Cumberland Pharmaceuticals
`Inc., 12 pages, (2017).
`"AMINOSYN [prescribing information and label]," Hospira, Inc.,
`19 pages, (2012).
`"ASHP Guidelines on the Safe Use of Automated Compounding
`Devices for the Preparation of Parenteral Nutrition Admixtures,"
`Automation and Information Technology-Guidelines, 63-67, (2000).
`"Chapter 18: Preparation of Parenteral Nutrition," Aseptic Process(cid:173)
`ing Manual, NHS Technical Specialist Education and Training
`Group, 24 pages, (2018).
`"Cysteine Hydrochloride Injection [Material Safety Data Sheet],"
`Hospira Inc., 6 pages, (2011).
`"Cysteine Hydrochloride Injection [prescribing information]," Hospira,
`Inc., 4 pages, (2004). [Retrieved from the Internet Dec. 28, 2016:
`<URL: https://dailymed.nlm.nih.gov/dailymed/archives/fdaDrug Info.
`cfm?archiveid~ 113819>].
`"Cysteine," TOXNET: Toxicology Data Network, National Library
`of Medicine HSDB Database, 20 pages, (2016). [Retrieved from the
`Internet Jun. 27, 2017: <URL: https://toxnet.nlm.nih.gov/cgi-bin/
`sis/search/a?dbs+hsdb:@term+@DOCNO+2109>].
`"Cysteine: Pediatric drug information," Lexicomp, Inc., 4 pages,
`(1978).
`"Determination That Cysteine Hydrochloride Injection, USP, 7.25%,
`Was Not Withdrawn From Sale for Reasons of Safety or Effective(cid:173)
`ness," Federal Register, 75(107):31790-31791, (2010).
`"Effect of L-Cysteine (Acetium® Capsules) in Restoration of the
`Structure and Function of Gastric Mucosa After H. pylori Eradica(cid:173)
`tion in Patients with Atrophic Gastritis. A randomized, controlled
`trial.," Study Protocol, BIO HIT HealthCare, 45 pages, (2016).
`"Guideline on the Use of Parenteral Nutrition in Neonatal and
`Paediatric Units," Clinical Practice Guideline, Royal College of
`Physicians in Ireland, 46 pages, (2016).
`"L-Cysteine [product information]," Sigma-Aldrich, Inc., 2 pages,
`(2003).
`"L-Cysteine Hydrochloride [prescribing information and label]",
`Sandoz Inc., 6 pages, (2010).
`"L-Cysteine Hydrochloride Injection, USP [prescribing informa(cid:173)
`tion]," American Regent, Inc., 2 pages, (2009).
`"PROSOL [prescribing information and label]," Baxter Healthcare
`Corporation, 14 pages, (2014).
`"Safe Practices for Parenteral Nutrition Formulations," National
`Advisory Group on Standards and Practice Guidelines for Parenteral
`
`Nutrition, Journal of Parenteral and Enteral Nutrition, 22(2):49-66,
`(1998). [Retrieved from the Internet Mar. 12, 2015: <URL:https://
`onlinelibrary.wiley.corn/doi/10.1177 /0 l 4860719802200249>].
`"Scientific Opinion on the safety and efficacy of L-cysteine hydro(cid:173)
`chloride monohydrate as a flavouring additive for pets," European
`Food Safety Authority Journal, 11(10):3437, 13 pages, (2013).
`"The Provision of Parenteral Nutrition within Neonatal Ser(cid:173)
`vices-A Framework for Practice," British Association of Perinatal
`Medicine, 27 pages, (2016).
`"Travasol [prescribing information and label]," Baxter Healthcare
`Corporation, 19 pages, (2017).
`"Trophamine [prescribing information and label]," B. Braun Medi(cid:173)
`cal Inc., 21 pages, (2014).
`"Trophamine® (Amino Acid Injections) [package insert]," B. Braun
`Medical Inc., pp. 5-16, (2003).
`Abdulrazik et al., "Formulation for Slow Release of Oral Radiation(cid:173)
`Protection Drugs," Int. J. Nucl. Med. Biol., 11(1):53-54, (1984).
`Advenier et al., "Aluminum Contamination of Parenteral Nutrition
`and Aluminum Loading in Children on Long-Term Parenteral
`Nutrition," Journal of Pediatric Gastroenterology and Nutrition,
`36(4):448-453, (2003). [Retrieved from the Internet Jun. 6, 2018:
`<URL: https://joumals.lww.corn/jpgn/Fulltext/2003/04000/ Aluminum_
`Contamination_of _Parenteral_Nutrition_and.5 .aspx#pdf-link>].
`Allen, Jr., Loyd V., "L-Cysteine Hydrochloride 50 mg/mL Injec(cid:173)
`tion," U.S. Pharmacist, 36(9):41-42, (2011). [Retrieved from the
`Internet May 26, 2016: <URL:https://www.uspharmacist.com/article/
`lcysteinehydrochloride50mgrnlinjection> ].
`Allen, Loyd V., "Chapter 1: Guidelines for Compounding Prac(cid:173)
`tices," The Art, Science, and Technology of Pharmaceutical Com(cid:173)
`pounding, 4th Ed.:1-18, (2012).
`Allwood et al., "Compatibility and Stability of Additives in Parenteral
`Nutrition Admixtures," Nutrition, 14(9):697-706, (1998).
`Anderson et al., "Physical Compatibility of Calcium Chloride and
`Sodium Glycerophosphate in Pediatric Parenteral Nutrition Solu(cid:173)
`tions," Journal of Parenteral and Enteral Nutrition, 40(8): 1166-
`1169, (2016, Epub. 2015). [Retrieved from the Internet Oct. 24,
`2015: <URL: https://onlinelibrary.wiley.com/doi/epdf/10.1177 /
`0148607115592673>].
`Ayers et al., "A.S.P.E.N. Parenteral Nutrition Safety Consensus
`Recommendations," Scholarship and Professional Work-COPHS,
`Butler University, 66 pages, (2014).
`Baines et al., "The Association Between Cysteine, Bone Turnover,
`and Low Bone Mass," Calcif Tissue Int, 81(6):450-454, (2007).
`Balogh, Judit Kovacsne, "Preparation and examination of TPN
`systems for the individual clinical therapy," (Ph.D. Thesis), Sem(cid:173)
`melweis University, Hungary, 116 pages, (2007).
`Bengoa et al., "Amino acid-induced hypercalciuria in patients on
`total parenteral nutrition," The American Journal of Clinical Nutri(cid:173)
`tion, 38(2):264-269, (1983). [Retrieved from the Internet Dec. 14,
`2017: <URL: https://academic.oup.corn/ajcn/article-abstract/38/2/
`264/4690894>].
`Bettner et al., "Effects of pH, Temperature, Concentration, and Time
`on Particle Counts in Lipid-Containing Total Parenteral Nutrition
`Admixtures," Journal of Parenteral andEnteral Nutrition, 10(4):375-
`380, (1986). [Retrieved from the Internet Mar. 10, 2015: <URL:
`https :// onlinelibrary. wiley.com/ doi/ epdf/ 10 .11 77 /
`0148607186010004375>].
`Bishop et al., "Aluminum Neurotoxicity in Preterm Infants Receiv(cid:173)
`ing Intravenous-Feeding Solutions," The New England Journal of
`Medicine, 336(22):1557-1561, (1997). [Retrieved from the Internet
`Jun. 5, 2018: <URL: https://www.nejm.org/doi/full/10.1056/
`NEJM199705293362203>].
`Bistrian, Bruce R., "Brief History of Parenteral and Enteral Nutri(cid:173)
`tion in the Hospital in the USA," Nestle Nutr Inst Workshop Ser
`Perform Program, 12:127-136, (2009).
`Bjelton et al., "Availability of Cysteine and ofL-2-0xo-Thiazolidine-
`4-Carboxylic Acid as a Source of Cysteine in Intravenous Nutri(cid:173)
`tion," Journal of Parenteral and Enternal Nutrition, 14(2):177-182,
`(1990).
`Bohrer et al., Aluminum Loading in Preterm Neonates Revisited,
`JPGN, 51(2):237-241, (2010).
`
`Eton Ex. 1101
`2 of 43
`
`

`

`US 10,478,453 Bl
`Page 3
`
`(56)
`
`References Cited
`
`OTHER PUBLICATIONS
`
`Borges-Santos et al., "Plasma glutathione of HIV+ patients responded
`positively and differently to dietary supplementation with cysteine
`or glutamine," Nutrition, 28(7-8):753-756, (2012).
`Boullata et al., "A.S.P.E.N. Clinical Guidelines: Parenteral Nutrition
`Ordering, Order Review, Compounding, Labeling, and Dispens(cid:173)
`ing," Journal of Parenteral and Enteral Nutrition, 38(3):334-377,
`(2014).
`Brigham et al., "The Concentrations of Cysteine and Cystine in
`Human Blood Plasma," J Clin Invest., 39(11):1633-1638, (1960).
`Brown et al., "Potential Aluminum Exposure from Parenteral Nutri(cid:173)
`tion in Patients with Acute Kidney Injury," The Annals of
`Pharmacotherapy, 42(10):1410-1415, (2008).
`Bulbul et al., "Letter to the Editor: Nutritional support in preterm
`infants," Pediatrics and Neonatology, 58(6):562, (2017).
`Bullock et al., "Emulsion Stability in Total Nutrient Admixtures
`Containing a Pediatric Amino Acid Formulation," Journal of Parenteral
`and Enteral Nutrition, 16(1):64-68, (1992). [Retrieved from the
`Internet Feb. 10, 2015: <URL: https://onlinelibrary.wiley.com/doi/
`pdf/10.1177/014860719201600164>].
`Calkins et al., "Effect of High-Dose Cysteine Supplementation on
`Erythrocyte Glutathione: a Double-Blinded, Randomized Placebo
`Controlled Pilot Study in Critically III Neonates," JPEN J Parenter
`Enteral Nutr., 40(2):226-234, (2016).
`Carlson et al., "Neonatal Parenteral and Enteral Nutrition: A Resource
`Guide for the Student and Novice Neonatal Nurse Practitioner,"
`National Association of Neonatal Nurse Practitioners, 23 pages,
`(2010).
`Connelly et al., "Congenital Hypothyroidism Caused by Excess
`Prenatal Maternal Iodine Ingestion," The Journal of Pediatrics,
`161(4):760-762, (2012).
`Courtney-Martin et al., "Plasma Aluminum Concentrations in Pedi(cid:173)
`atric Patients Receiving Long-Term Parenteral Nutrition," Journal
`of Parenteral and Enteral Nutrition, 39(5):578-585, (2014).
`Courtney-Martin et al., "The Addition of Cysteine to the Total
`Sulphur Amino Acid Requirement as Methionine Does Not Increase
`Erythrocytes Glutathione Synthesis in the Parenterally Fed Human
`Neonate," Pediatric Research, 67(3):320-324, (2010).
`Darkwa et al., "Antioxidant Chemistry: Oxidation of L-Cysteine
`and Its Metabolites by Chlorite and Chlorine Dioxide," J. Phys.
`Chem. A., 108(26):5576-5587, (2004).
`De Cloet et al., "Physicochemical stable standard all-in-one parenteral
`nutrition admixtures for infants and children in accordance with the
`ESPGHAN/ESPEN guidelines," Nutrition, 49:41-47, (2018).
`Delange, F., "Optimal Iodine Nutrition during Pregnancy, Lactation
`and the Neonatal Period," Int J Endocrinol Metab, 2(1)1-12, (2004).
`Delange, Francois, "Iodine deficiency in Europe and its conse(cid:173)
`quences: an update," Eur J Nucl Med, 29(Suppl. 2):S404-S416,
`(2002).
`Delange, Francois, "Iodine requirements during pregnancy, lacta(cid:173)
`tion and the neonatal period and indicators of optimal iodine
`nutrition," Public Health Nutrition: 10(12A):1571-1580, (2007).
`Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat,
`Fatty Acids, Cholesterol, Protein, and Amino Acids, The National
`Academies Press, 1358 pages, (2002). [Retrieved from the Internet
`Dec. 12, 2017: <URL: http://www.nap.edu/10490>].
`Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic,
`Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum,
`Nickel, Silicon, Vanadium, and Zinc, National Academy Press, 800
`pages, (2000). [Retrieved from the Internet Dec. 16, 2018: <URL:
`http://www.nap.edu/catalog/ 10026.htrnl>].
`Dilger et al., "Excess Dietary L-Cysteine, but Not L-Cystine, Is
`Lethal for Chicks but Not for Rats or Pigs," The Journal of
`Nutrition, 137(2):331-338, (2007). [Retrieved from the Internet Jun.
`28, 2017: <URL:https://academic.oup.com/jn/article/137 /2/331/
`4664534>].
`Domingo et al., "Risks of aluminium exposure during pregnancy,"
`Contributions to Science, 1(4):479-487, (2000).
`Dumortier et al., "Development of a Thermogelling Ophthalmic
`Formulation of Cysteine," Drug Development and Industrial Phar-
`
`macy, 32(1):63-72, (2006). [Retrieved from the Internet May 12,
`2015: <URL: https://www.tandfonline.com/doi/full/l 0.1080/
`03639040500390934>].
`El-Shenawy et al., "Nephrotoxicity of sodium valproate and pro(cid:173)
`tective role of L-cysteine in rats at biochemical and histological
`levels," J Basic Clin Physiol Pharmacol, 27(5):497-504, (2016).
`[Retrieved from the Internet May 4, 2016: <URL: https://www.
`degruyter.com/view/j/jbcpp.2016.27.issue-5/jbcpp-2015-0106/jbcpp-
`2015-0106 .xml>].
`Fewtrell et al., "Aluminium exposure from parenteral nutrition in
`preterm infants and later health outcomes during childhood and
`adolescence," Symposium 2: Micronutirents under the Microscope,
`Proceedings of the Nutrition Society, 70(3):299-304, (2011 ). [Retrieved
`from the Internet Jun. 4, 2018: <URL: https://www.cambridge.org/
`core/journals/proceedings-of-the-nutrition-society/article/aluminium(cid:173)
`expo sure-from -parenteral-nutrition -in -preterm-inf ants-and-later(cid:173)
`heal th -outcomes -during -childhood- and- ado le s c enc e /
`F5D0A6 l 096 l 6E8C9D7F8C2C7072 l 3860/ core-reader>].
`Flora et al., "Chelation in Metal Intoxication," Int. J. Environ. Res.
`Public Health, 7(7):2745-2788, (2010).
`Fortenberry et al., "Evaluating Differences in Aluminum Exposure
`through Parenteral Nutrition in Neonatal Morbidities," Nutrients,
`9(11):El249, 6 pages, (2017).
`Frey et al., "Confirming the Causative Role of Acetaminophen in
`Indeterminate Acute Liver Failure Using Acetaminophen-Cysteine
`Adducts," J. Med. Toxicol., 11(2):218-222, (2015).
`Furst et al., "Parenteral nutrition by a solution of crystalline amino
`acids," Acta Med Scand Suppl., 472:283-293, (1967).
`Fusch et al., "Neonatology/Paediatrics----Guidelines on Parenteral
`Nutrition, Chapter 13," GMS German Medical Science, 7(Doc15):23
`pages, (2009).
`Ghirri et al., "Iodine Supplementation in the Newborn," Nutrients,
`6(1):382-390, (2014).
`Gura et al., "Aluminum contamination in products used in parenteral
`nutrition: Has anything changed?," Nutrition, 26(6):585-594, (2010).
`Gura et al., "Recent developments in aluminium contamination of
`products used in parenteral nutrition," Curr Opin Clin Nutr Metab
`Care, 9(3):239-246, (2006).
`Hardy et al., "Formulation, Stability, and Administration of Parenteral
`Nutrition With New Lipid Emulsions," Nutrition in Clinical Prac(cid:173)
`tice, 24(5):616-625, (2009).
`Hardy et al., "P.83: Stability of aqueous cysteine solutions for TPN
`[Abstract]," Clinical Nutrition, 12(Suppl 2):61, (1993).
`Harman et al., "Free Radical Metabolites ofL-Cysteine Oxidation,"
`The Journal of Biological Chemistry, 259(9):5606-5611, (1984).
`[Retrieved from the Internet Feb. 6, 2017: <URL: http://www.jbc.
`org/content/259/9/5606.full.pdf>].
`Heird et al., "Pediatric Parenteral Amino Acid Mixture in Low Birth
`Weight Infants," Pediatrics, 81(1):41-50, (1988). [Retrieved from
`the Internet Dec. 8, 2017: <URL: http:/ /pediatrics.aappublications.
`org/content/8111/41>].
`Hellstrom et al., "Sal863. L-Cysteine Slow-Release Capsule For(cid:173)
`mulation in Prevention of Gastric Carcinogenesis Associated With
`Atrophic Gastritis," AGAAbstracts, 146(5, Suppl l):S-315, (2014).
`Helms et al., "Cysteine supplementation results in normalization of
`plasma taurine concentrations in children receiving home parenteral
`nutrition," J Pediatr, 134(3):358-361, (1999).
`Hernandez-Sanchez et al., "Aluminium in parenteral nutrition: a
`systematic review," European Journal of Clinical Nutrition, 67(3):230-
`238, (2013).
`Heyman et al., "Aluminum Does Not Accumulate in Teenagers and
`Adults on Prolonged Parenteral Nutrition Containing Free Amino
`Acids," Journal of Parenteral and Enteral Nutrition, 10(1):86-87,
`(1986).
`Ho et al., "Trend of Nutritional Support in Preterm Infants,"
`Pediatrics and Neonatology, 57(5):365-370, (2016).
`Hu et al., "Efficacy and safety of acetylcysteine in "non(cid:173)
`acetaminophen" acute liver failure: A meta-analysis of prospective
`clinical trials," Clin Res Hepatol Gastroenterol, 39(5):594-599,
`(2015).
`Hulst, Jessie, "Principles of feeding the preterm infant," 36th
`ESPEN Congress, Geneva, 44 pages, (2014).
`
`Eton Ex. 1101
`3 of 43
`
`

`

`US 10,478,453 Bl
`Page 4
`
`(56)
`
`References Cited
`
`OTHER PUBLICATIONS
`
`Huston et al., "Calcium Chloride in Neonatal Parenteral Nutrition
`Solutions with and without Added Cysteine: Compatibility Studies
`Using Laser and Micro-Flow Imaging Methodology," PLoS ONE,
`10(8):eO 136894, (2015).
`Huston et al., "Calcium chloride in neonatal parenteral nutrition: A
`15 year experience," Journal of Neonatal-Perinatal Medicine, 10(1):33-
`38, (2017).
`Huston et al., "Calcium Chloride in Neonatal Parenteral Nutrition:
`Compatibility Studies Using Laser Methodology," PLoS ONE,
`9(9):el06825, (2014).
`Ishii et al., "A case of drug-induced ductopenia resulting in fatal
`biliarv cirrhosis," Liver, 13(4):227-231, (1993).
`Ishii et al., "Cystathionine y-Lyase-deficient Mice Require Dietary
`Cysteine to Protect against Acute Lethal Myopathy and Oxidative
`Injury," The Journal of Biological Chemistry, 285(34):26358-
`26368, (2010).
`Jadhav et al., "Parenteral Amino Acid and Metabolic Acidosis in
`Premature Infants," JPEN J Parenter Enteral Nutr., 31(4):278-283,
`(2007).
`Janakyet al., "Mechanisms ofL-Cysteine Neurotoxicity," Neurochemi(cid:173)
`cal Research, 25(9/10):1397-1405 (2000).
`Ji et al., "Excessive L-cysteine induces vacuole-like cell death by
`activating endoplasmic reticulum stress and mitogen-activated pro(cid:173)
`tein kinase signaling in intestinal porcine epithelial cells," Amino
`Acids, 48( 1 ): 149-156, (2015).
`John et al., "Total parenteral nutrition usage trends in the United
`States," Journal of Critical Care, 40:312-313, (2017).
`Kartal et al., "Compatibility of chewing gum excipients with the
`amino acid L-cysteine and stability of the active substance in
`directly compressed chewing gum formulation," Journal of Phar(cid:173)
`macy and Pharmacology, 60(9):1131-1138, (2008).
`Kartal et al., "Formulation and in-vivo evaluation of L-cysteine
`chewing gums for binding carcinogenic acetaldehyde in the saliva
`during smoking," Journal of Pharmacy and Pharmacology, 59( 10): 1353-
`1358, (2007).
`Kartal-Hodzic, Alma, "Formulation studies for eliminating saliva
`carcinogenic acetaldehyde with L-cysteine containing chewing gum,"
`(Academic Dissertation), Division of Biopharmaceutics and
`Pharrnacokinetics, University of Helsinki, Finland, 60 pages, (2012).
`Klein et al., "Hypocalcemia Complicating Deferoxamine Therapy
`in an Infant with Parenteral Nutrition-Associated Aluminum Over(cid:173)
`load: Evidence for a Role of Aluminum in the Bone Disease of
`Infants," Journal of Pediatric Gastroenterology and Nutrition, 9(3):400-
`403, ( 1989). [Retrieved from the IntemetJun. 5, 2018: <URL:https://
`journals .lww.com/jpgn/ Abstract/ 1989/ 10000/Hypocalcemia_
`Complicating_Deferoxamine_ Therapy _in.24.aspx>].
`Klein, Catherine J., "Nutrient Requirements For Preterm Infant
`Formulas," The Journal of Nutrition, 132(6 Suppl l):1395S-1577S,
`(2002). [Retrieved from the Internet Dec. 6, 2017: <URL: http://
`jn.nutrition.org>].
`Kolaric et al., "Solutions Preparing for Total Parenteral Nutrition for
`Children," Proceedings of the 7th WSEAS International Conference
`on Mathematics & Computers in Biology & Chemistry, Cavtat,
`Croatia, 6 pages, (2006).
`Koletzko et al., "Guidelines on Paediatric Parenteral Nutrition: 3.
`Amino Acids," J. Pediatr. Gastroenterol. Nutr., 4l(Suppl. 2):Sl2-
`Sl8, (2005).
`Komura et al., "Increased Incidence of Cholestasis during Total
`Parenteral Nutrition in Children," The Kurume Medical Journal,
`40(1):7-11, (1993).
`Koo et al., "Response to aluminum in parenteral nutrition during
`infancy," The Journal of Pediatrics, 109(5):877-883, (1986).
`Laine et al., "Cysteine usage increases the need for acetate in
`neonates who receive total parenteral nutrition," The American
`Journal of Clinical Nutrition, 54(3):565-567, (1991). [Retrieved
`from the Internet Apr. 14, 2015: <URL: https://academic.oup.corn/
`ajcn/article-abstract/ 54/3/ 565/4694399>].
`Lapillonne et al., "Quality of newborn care: adherence to guidelines
`for parenteral nutrition in preterm infants in four European coun-
`
`tries," BMJ Open, 3(9):E003478, 8 pages, (2013). [Retrieved from
`the Internet Jun. 6, 2018: <URL: https://bmjopen.bmj.corn/content/
`3/9/e003478>].
`Larchet et al., "Aluminium Loading in Children Receiving Long(cid:173)
`term Parenteral Nutrition," Clinical Nutrition, 9(2):79-83, (1990).
`Lee et al., "AASLD Position Paper: The Management of Acute
`Liver Failure: Update 2011," Hepatology, 1-22 and Corrections,
`(2011).
`Lee et al., "Introduction to the Revised American Association for the
`Study of Liver Diseases Position Paper on Acute Liver Failure
`2011," Hepatology, 55(3):965-967, (2012).
`Leung et al., "Consequences of excess iodine," Nat Rev Endocrinol.,
`10(3):136-142, (2014).
`Leyden et al., "Stabilization of Solutions of Cysteine and its
`Derivatives," Can. J. Biochem., 45(4):611-614, (1967). [Retrieved
`from the Internet Nov. 12, 2014: <URL: https://www.nrcresearchpress.
`corn/doi/pdf/10.1139/067-071>].
`Li et al., "Acute and sub-chronic toxicity of glucose----cysteine
`Maillard reaction products in Sprague-Dawley rats," Food and
`Chemical Toxicology, 80:271-276, (2015).
`Look et al., "Is the Increase in Serum Cystathionine Levels in
`Patients with Liver Cirrhosis a Consequence of Impaired Homocysteine
`Transsulfuration at the Level of y-Cystathionase?," Scand J
`Gastroenterol, 35(8):866-872, (2000). [Retrieved from the Internet
`Oct. 25, 2014: <URL: https://www.tandfonline.com/doi/abs/10.1080/
`003655200750023255>].
`Mackay et al., "Physical Compatibility of Sodium Glycerophosphate
`and Calcium Gluconate in Pediatric Parenteral Nutrition Solutions,"
`JPEN J Parenter Enteral Nutr, 39(6):725-728, (2015, Epub. 2014).
`[Retrieved from the Internet Apr. 6, 2014: <URL: http:/ /pen.sagepub.
`corn/content/early/2014/03/31/0148607114528982>].
`Mackay et al., "The Solubility of Calcium and Phosphate in Two
`Specialty Amino Acid Solutions," Journal of Parenteral and Enteral
`Nutrition, 20( 1 ):63-66, ( 1996). [Retrieved from the Internet Apr. 17,
`2015: <URL: https://onlinelibrary.wiley.com/doi/epdf/10.1177 /
`014860719602000163>].
`Malloy et al., "Cyst( e )ine measurements during total parenteral
`nutrition," The American Journal of Clinical Nutrition, 37(2):188-
`191, (1983). [Retrieved from the Internet Apr. 14, 2015: <URL:
`https :// academic .oup .com/ aj en/ article-abstract/3 7 /2/ 188/
`4690722>].
`Malloy et al., "Cysteine Supplementation During Total Parenteral
`Nutrition (TPN) [Abstract]," Clinical Nutrition, l(Suppl.):49, (1982).
`Malloy et al., "Cysteine Supplementation of Total Parenteral Nutri(cid:173)
`tion: the Effect in Beagle Pups," Pediatric Research, 18(8):747-751,
`(1984).
`Malloy et al., "Total Parenteral Nutrition in Sick Preterm Infants:
`Effects of Cysteine Supplementation with Nitrogen Intakes of 240
`and 400 mg/kg/day," Journal of Pediatric Gastroenterology and
`Nutrition, 3(2):239-244, (1984).
`Manz, Friedrich, "L-Cysteine in metabolic acidosis of low-birth(cid:173)
`weight infants," Am J Clin Nutr, 57(3):455-456, (1993). [Retrieved
`from the Internet Apr. 16, 2015: <URL: https://academic.oup.corn/
`ajcn/article-abstract/57 /3/455/4715721>].
`Mattox et al., "Chapter 142: Parenteral Nutrition," Pharmacotherapy:
`A Pathophysiologic Approach, lOe, McGraw Hill, Ed. Joseph T.
`DiPiro et al., 38 pages, (2016). [Retrieved from the Internet Dec. 5,
`2017: <URL: https://accesspharmacy.mhrnedical.corn/content.aspx?
`bookid~ 186 l&sectionid~ 146076679>].
`McCarthy et al., "Standardised versus Individualized Parenteral
`Nutrition," Irish Medical Journal, 109(4): 10 pages, (2016). [Retrieved
`from the Internet Jun. 6, 2018: <URL: http://imj.ie/standardised(cid:173)
`versus-indi v iduali sed-paren teral-n utri ti on -further-food- for(cid:173)
`thought/>].
`McClave et al., "Guidelines for the Provision and Assessment of
`Nutrition Support Therapy in the Adult Critically Ill Patient: Society
`of Critical Care Medicine (SCCM) and American Society for
`Parenteral and Enteral Nutrition (A.S.P.E.N.)," Journal of Parenteral
`and Enteral Nutrition, 40(2):159-211, (2016).
`Metabolic Processes in the Foetus and Newborn Infant, Nutricia
`Symposium, Ed. J. H. P. Jonxis et al., H. E. Stenfert Kroese N.V.,
`317 pages, (1971).
`
`Eton Ex. 1101
`4 of 43
`
`

`

`US 10,478,453 Bl
`Page 5
`
`(56)
`
`References Cited
`
`OTHER PUBLICATIONS
`
`Miller et al., "Decreased Cysteine and Pro line Synthesis in Parenter(cid:173)
`ally Fed, Premature Infants," Journal of Pediatric Surgery, 30(7):953-
`958, (1995).
`Miller, Sarah J., "Parenteral Nutrition," U.S. Pharmacist, 7(HS10-
`HS20):31 pages, (2006). [Retrieved from the Internet Sep. 26, 2018:
`<URL: https://www.uspharmacist.com/ article/parenteral(cid:173)
`nutrition>].
`Mirtallo et al., "Safe Practices for Parenteral Nutrition," Journal of
`Parenteral and Enteral Nutrition, 28(6):S39-S70, (2004). [Retrieved
`from the Internet Jan. 23, 2014: <URL: https://journals.sagepub.
`corn/doi/abs/10.1177/0148607104028006s39>].
`Moreno et al., "Aluminium in the neonate related to parenteral
`nutrition," Acta Paediatr, 83(1):25-29, (1994).
`Moreno Villares et al., "Current use of parenteral nutrition in a
`pediatric hospital. Comparison to the practise 8 years ago," Nutr.
`Hosp., 20(1):46-51, (2005).
`Miihlebach, Stefan, "Parenteral Nutrition: The Role of the Pharma(cid:173)
`cist in the Era of 3-chamber Bags," 27th ESPEN Congress, Brus(cid:173)
`sels, 49 pages, (2005).
`Mundi et al., "Prevalence of Home Parenteral and Enteral Nutrition
`in the United States [Abstract]," Nutr Clin Pract., 32(6):799-805,
`(2017). [Retrieved from the Internet Jun. 6, 2018: <URL: http://
`journals.sagepub.corn/doi/pdf/ 10.1177 /0884533617718472>].
`Murphy et al., "Annual Summary of Vital Statistics: 2013-2014,"
`Pediatrics, 139(6):e20163239, (2017). [Retrieved from the Internet
`Jun. 6, 2018: <URL: http:/ /pediatrics.aapublications.org/content/
`139/6/e20163239>].
`Nguyen et al., "Effect of Increasing Glutathione With Cysteine and
`Glycine Supplementation on Mitochondrial Fuel Oxidation, Insulin
`Sensitivity, and Body Composition in Older HIV-Infected Patients,"
`J Clin Endocrinol Metab,, 99(1):169-177, (2014). [Retrieved from
`the Internet Dec. 12, 2017: <URL: https://academic.oup.corn/jcern/
`article-abstract/99/1/169/2836223>].
`Niermeyer et al., "Optimized calcium/phosphorus solubility in a
`parenteral nutrition solution containing dicarboxylic amino acids
`and cysteine," Journal of the American College of Nutrition, 5(5):459-
`466, (1986). [Retrieved from the Internet Apr. 21, 2015: <URL:
`https://www.tandfonline.com/doi/pdf/ 10.1080/07315724.1986.
`10720149>].
`Nishiyama et al., "Transient Hypothyroidism or Persistent
`Hyperthyrotropinemia in Neonates Born to Mothers with Excessive
`Iodine Intake," Thyroid, 14(2): 1077-1083, (2004).
`Olney et al., "Brain Damage in Infant Mice following Oral Intake
`of Glutamate, Aspartate or Cysteine," Nature, 227(5258):609-611,
`(1970).
`0 'N ea! et al., "Compliance with safe practices for preparing parenteral
`nutrition formulations," Am J Health Syst Pharm, 59(3):264-269,
`(2002).
`Parikh et al., "Physical compatibility of neonatal total parenteral
`nutrient admixtures containing organic calcium and inorganic phos(cid:173)
`phate salts," Am J Health Syst Pharm, 62(11): 1177-1183, (2005).
`Patanwala et al., "Antiemetic Therapy for Nausea and Vomiting in
`the Emergency Department," The Journal of Emergency Medicine,
`39(3):330-336, (2010).
`Patel et al., "Total parenteral nutrition for premature infants: prac(cid:173)
`tice aspects," Journal of Nature and Science (JNSCI), 3(1):e301, 6
`pages, (2017).
`Patt et al., "Cysteine Protection against X Irradiation," Science,
`110(2852):213-214, (1949).
`Paulikova et al., "Iodine toxicity in ruminants," Vet. Med.-Czech,
`47(12):343-350, (2002).
`Pertkiewicz et al., "Basics in clinical nutrition: Stability of parenteral
`nutrition admixtures," e-Spen, the European e-Journal of Clinical
`Nutrition and Metabolism, 4(3):ell 7-ell9, (2009).
`Plogsted et al., "Parenteral Nutrition L-Cysteine Product Shortage
`Considerations," Nutrition in Clinical Practice, 30( 4):579-580, (2015).
`Poole et al., "Aluminum Exposure From Pediatric Parenteral Nutri(cid:173)
`tion: Meeting the New FDA Regulation," Journal of Parenteral and
`Enteral Nutrition, 32(3):242-246, (2008).
`
`Poole et al., "Aluminum Exposure in Neonatal Patients Using the
`Least Contaminated Parenteral Nutrition Solution Products," Nutri(cid:173)
`ents, 12(4):1566-1574, (2012).
`Pyati et al., "Absorption of iodine in the neonate following topical
`use of povidone iodine," The Journal of Pediatrics, 91(5):825-828,
`(1977).
`Rabbani et al., "Glycation research in amino acids: a place to call
`home," Amino Acids, 42:1087-1096, (2012). [Retrieved from the
`Internet May 10, 2016: <URL: https://www.researchgate.net/
`publication/47 567399>].
`Rassin, David Keith, "Essential and Non-essential Amino Acids in
`Neonat

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket